vaccine
Researchers in the UK have been granted £1.7 million (€1.98 million) to develop a lung cancer vaccine. The "LungVax" they aim to develop would be the world's first vaccine against lung cancer in people at risk of developing it. The technology for the new vaccine will be similar to that used for the Oxford/AstraZeneca vaccine against COVID-19. Cancer cases expected to grow by more than 20% in Europe by 2045 - WHO agencyThe funding will come from Cancer Research UK and the CRIS Cancer Foundation. "Cancer is a disease of our own bodies and it’s hard for the immune system to distinguish between wh...
Euronews (English)
The Czech authorities reported that there were 28 registered cases of whooping cough in the first week of January. That figure now stands at 3,084 – a number not seen since 1963. The highest rate of the illness is among 15 to 19-year-olds, who account for about one-third of the patients. According to Czech Health Minister Vlastimil Válek, the surge is likely attributable to a mix of a resurgence in respiratory diseases as society shifts away from stringent Covid measures, and incomplete immunization among children. Whooping cough is a highly infectious bacterial disease that affects the lungs ...
Euronews (English)
European lawmakers will seek stronger protection for trade secrets of pharmaceutical companies in talks with EU ministers on new compulsory licensing legislation after a plenary vote on their negotiating mandate held this week. New rules were proposed by the European Commission in April to give the bloc a single instrument for compulsory licensing. Negotiations to approve the final legislative text will start once EU ministers will finalise their own amendments to the commission’s proposal. Governments may grant compulsory licenses in exceptional circumstances allowing use of protected inventi...
Euronews (English)
Health officials are investigating whether there's a link between two new RSV vaccines and cases of a rare nervous system disorder in older US adults. The inquiry is based on fewer than two dozen cases seen among more than 9.5 million vaccine recipients, health officials said on Thursday. And the available information is too limited to establish whether the shots caused the illnesses, they added. But the numbers are higher than expected and officials are gathering more information to determine if the vaccines are causing the problem. The data was presented at a meeting of an expert panel that ...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら